PUBLISHER: Allied Market Research | PRODUCT CODE: 1225095
PUBLISHER: Allied Market Research | PRODUCT CODE: 1225095
The global wireless brain sensors market is envisioned to garner $1,566.7 million by 2031, growing from $677.8 million in 2021 at a CAGR of 9.0% from 2022 to 2031.
The market for wireless brain sensors is being driven primarily by factors, such as rising levels of stress, high prevalence of neurological illnesses as a result of lifestyle changes, and drastic changes in social contexts. In addition, the wireless brain sensors market is expanding due to rise in individuals experiencing brain-related disorders. Nevertheless, there are several factors impeding the growth of the wireless brain sensors market, including compatibility challenges, strict safety and validation rules, and difficulty comprehending the operation of the device.
Stringent regulations governing sensors use are projected to be the principal market restraint. When these sensors are implanted in the body, they frequently cause an immunological reaction, which can be troublesome for patients. As a result, the usage of such devices has been regulated or prohibited in a variety of applications, limiting the market revenue growth.
The demand for wireless brain sensors is expected to rise over the next few years due to a number of other factors, including changing social environment, rising research expenditures, technological advancements, rising awareness of neurological disorders, and increase in the prevalence of dementia. Brain sensors are always getting better owing to significant new advancements in brain-computer interfaces. The wireless brain sensors market may have a lot of opportunities in the next years due to untapped markets and technological improvement.
The World Health Organization (WHO) declared the COVID-19 virus a public health emergency as a result of its global spread since its discovery in December 2019. Globally, COVID-19 is having a negative impact, and the market for wireless brain sensor is particularly affected due to decline in healthcare sector. COVID-19 had an influence on significant supply chain snags, stock market volatility, declining company confidence, and escalating panic.
The key players profiled in this report include, NeuroSky, EMOTIV, Advanced Brain Monitoring, Inc., Koninklijke Philips N.V., Medtronic, Muse, Natus Medical Incorporated, Cadwell Industries, Inc., NeuroWave Systems Inc., and BrainScope.
Key Benefits For Stakeholders
By Product Type
By Application
By End User
By Region